Rheumatology International

, Volume 33, Issue 4, pp 903–911

The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-year follow-up study in middle-aged subjects

Original Article

Abstract

To determine the possible diagnostic and prognostic value of cartilage biomarkers in early-stage progressive and nonprogressive knee osteoarthritis (OA) in a population-based cohort of middle-aged subjects with chronic knee pain. Design tibiofemoral (TF) and patellofemoral (PF) radiographs were graded in 128 subjects (mean age at baseline, 45 ± 6.2 years) in 2002, 2005, and 2008. Cartilage degradation was assessed by urinary C-telopeptide fragments of type II collagen (uCTx-II), synthesis by serum type II A procollagen N-terminal propeptide (sPIIANP), and articular tissue turnover in general by cartilage oligomeric matrix protein (sCOMP). Several diagnostic associations were found between all studied biomarkers and progressive osteophytosis. COMP and CTx-II had a predictive value for subsequent progressive osteophytosis in multiple knee compartments and in case of CTx-II—also for progressive JSN. Over the first 3 years (2002–2005), significant associations were observed between COMP and progressive osteophytosis, whereas 3 years later (2005–2008) between CTx-II and progressive JSN. Thus, the associations between cartilage markers (COMP, CTx-II) and progression of radiographic OA features—osteophytes and JSN—were different between 2002–2005 and 2005–2008. Logistic regression revealed that for every unit increase in COMP level, there was 33 % higher risk for TF osteophyte progression. During early-stage OA, the presence and progression of osteophytosis is accompanied by increased level of cartilage biomarkers. This is the first study to demonstrate biochemical differences over the course of knee OA, illustrating a phasic nonpersistent character of OA with periods of progression and stabilization.

Keywords

Osteoarthritis Knee Cartilage biomarkers Radiographic progression Osteophyte 

References

  1. 1.
    Felson DT (2009) Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 11(1):203PubMedCrossRefGoogle Scholar
  2. 2.
    Brandt KD, Doherty M, Lohmander LS (2003) Introduction: the concept of osteoarthritis as failure of the diarthrodial joint. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis. Oxford University Press, New York, pp 69–71Google Scholar
  3. 3.
    Senior K (2000) Osteoarthritis research: on the verge of a revolution? Lancet 355(9199): 208PubMedCrossRefGoogle Scholar
  4. 4.
    Golightly YM, Marshall SW, Kraus VB, Renner JB, Villaveces A, Casteel C et al (2011) Biomarkers of incident radiographic knee osteoarthritis. Arthritis Rheum 63(8):2276–2283PubMedCrossRefGoogle Scholar
  5. 5.
    Kraus VB (2011) Osteoarthritis year 2010 in review: biochemical markers. Osteoarthritis Cartilage 19:346–353PubMedCrossRefGoogle Scholar
  6. 6.
    Ornetti P, Brandt K, Hellio-Le Graverand M-P, Hochberg M, Hunter DJ, Kloppenburg M et al (2009) OARSI–OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. Osteoarthritis Cartilage 17(7):856–863PubMedCrossRefGoogle Scholar
  7. 7.
    Eckstein F, Le Graverand MP, Charles HC, Hunter DJ, Kraus VB, Sunyer T et al (2011) Clinical, radiographic, molecular and MRI-based predictors of cartilage loss in knee osteoarthritis. Ann Rheum Dis 70(7):1223–1230PubMedCrossRefGoogle Scholar
  8. 8.
    Conaghan PG, Hunter DJ, Maillefert JF, Reichmann WM, Losina E (2011) Summary and recommendations of the OARSI FDA osteoarthritis assessment of structural change working group. Osteoarthritis Cartilage 19:606–610PubMedCrossRefGoogle Scholar
  9. 9.
    Spector TD, Hart DJ, Byrne J, Harris PA, Dacre JE, Doyle DV (1993) Definition of osteoarthritis of the knee for epidemiological studies. Ann Rheum Dis 52:790–794PubMedCrossRefGoogle Scholar
  10. 10.
    Bettica P, Cline G, Hart DJ, Meyer J, Spector TD (2002) Evidence for increased bone resorption in patients with progressive knee osteoarthritis. Arthritis Rheum 46(12):3178–3184PubMedCrossRefGoogle Scholar
  11. 11.
    Ding C, Garnero P, Cicuttini F, Scott F, Cooley H, Jones G (2005) Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown. Osteoarthritis Cartilage 13:198–205PubMedCrossRefGoogle Scholar
  12. 12.
    Kumm J, Tamm AE, Lintrop M, Tamm AO (2011) The prevalence and progression of radiographic knee osteoarthritis over 6 years in a population-based cohort of middle-aged subjects. Rheum Int. doi:10.1007/s00296-011-2221-3 Google Scholar
  13. 13.
    Sharif M, Kirwan JR, Elson CJ, Granell R, Clarke S (2004) Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum 50:2479–2488PubMedCrossRefGoogle Scholar
  14. 14.
    Sharif M, Kirwan J, Charni N, Sandell LJ, Whittles C, Garnero P (2007) A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis—associations with disease progression. Rheumatology 46:938–943PubMedCrossRefGoogle Scholar
  15. 15.
    van Spil WE, DeGroot J, Lems WF, Oostveen JC, Lafeber FP (2010) Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systemic review applying the consensus BIPED criteria. Osteoarthritis Cartilage 18:605–612PubMedCrossRefGoogle Scholar
  16. 16.
    Sharif M, Saxne T, Shepstone L, Kirwan JR, Elson CJ, Heinegard D et al (1995) Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol 34:306–310PubMedCrossRefGoogle Scholar
  17. 17.
    Vilim V, Olejarova M, Machacek S, Gatterova J, Kraus VB, Pavelka K (2002) Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 10:707–713PubMedCrossRefGoogle Scholar
  18. 18.
    Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H et al (2006) Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 65:1050–1054PubMedCrossRefGoogle Scholar
  19. 19.
    Hunter DJ, Li J, LaValley M, Bauer DC, Nevitt M, DeGroot J et al (2007) Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee study. Arthritis Res Ther 9(5):R108PubMedCrossRefGoogle Scholar
  20. 20.
    Sowers MF, Karvonen-Gutierrez CA, Yosef M, Jannausch M, Jiang Y, Garnero P et al (2009) Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women. Osteoarthritis Cartilage 17:1609–1614PubMedCrossRefGoogle Scholar
  21. 21.
    Dam EB, Byrjalsen I, Karsdal MA, Qvist P, Christiansen C (2009) Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI. Osteoarthritis Cartilage 17:384–389PubMedCrossRefGoogle Scholar
  22. 22.
    Garnero P, Ayral X, Rousseau J-C, Christgau S, Sandell LJ, Dougados M et al (2002) Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 10:2613–2624CrossRefGoogle Scholar
  23. 23.
    Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H et al (2006) Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 65:1050–1054PubMedCrossRefGoogle Scholar
  24. 24.
    Cibere J, Zhang H, Garnero P, Poole AR, Lobanok T, Saxne T et al (2009) Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum 60:1372–1380PubMedCrossRefGoogle Scholar
  25. 25.
    Schouten JS, Van den Ouweland FA, Valkenburg HA, Lamberts SW (1993) Insulin-like growth factor-1: a prognostic factor of knee osteoarthritis. Br J Rheumatol 32:274–280PubMedCrossRefGoogle Scholar
  26. 26.
    Petersson IF, Boegard T, Svensson B, Heinegard D, Saxne T (1998) Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol 37:46–50PubMedCrossRefGoogle Scholar
  27. 27.
    Sugiyama S, Itokazu M, Suzuki Y, Shimizu K (2003) Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis. Ann Rheum Dis 62:27–32PubMedCrossRefGoogle Scholar
  28. 28.
    Tamm A, Lintrop M, Veske K, Hansen U, Tamm A (2008) Prevalence of patello- and tibiofemoral osteoarthritis in Elva, Southern Estonia. J Rheumatol 35:543–544PubMedGoogle Scholar
  29. 29.
    Boegard T, Rudling O, Petersson IF, Sanfridsson J, Saxne T, Svensson B et al (1998) Joint-space width in the axial view of the patello-femoral joint. Definitions and comparison with MR imaging. Acta Radiol 39:24–31PubMedGoogle Scholar
  30. 30.
    Nagaosa Y, Mateus M, Hassan B, Lanyon B, Doherty M (2000) Development of logically devised line drawing atlas for grading of knee osteoarthritis. Ann Rheum Dis 59:587–595PubMedCrossRefGoogle Scholar
  31. 31.
    Botha-Scheepers S, Watt I, Breedveld FC, Kloppenburg M (2005) Reading radiographs in pairs or in chronological order influences radiological progression in osteoarthritis. Rheumatology 44:1452–1455PubMedCrossRefGoogle Scholar
  32. 32.
    Hashimoto S, Creighton-Achermann L, Takahashi K, Amiel D, Coutts RD, Lotz M (2002) Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 10:180–187PubMedCrossRefGoogle Scholar
  33. 33.
    Blaney Davidson EN, Vitters EL, van Beuningen HM, van de Loo FAJ, van den Berg WB, van der Kraan PM (2007) Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum 56:4065–4073PubMedCrossRefGoogle Scholar
  34. 34.
    Gelse K, Söder S, Eger W, Diemtar T, Aigner T (2003) Osteophyte development—molecular characterization of differentiation stages. Osteoarthritis Cartilage 11:141–148PubMedCrossRefGoogle Scholar
  35. 35.
    Kumm J, Tamm AE, Veske K, Lintrop M, Tamm AO (2006) Associations between cartilage oligomeric matrix protein and several articular tissues in early knee joint osteoarthritis. Rheumatology 45:1308–1309PubMedCrossRefGoogle Scholar
  36. 36.
    Kumm J, Tamm AE, Lintrop M, Tamm AO (2009) Associations between ultrasonographic findings and bone/cartilage biomarkers in patients with early-stage knee osteoarthritis. Calcif Tissue Int 85:514–522PubMedCrossRefGoogle Scholar
  37. 37.
    Di Cesare PE, Fang C, Leslie MP, Tulli H, Perris R, Carlson CS (2000) Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts. J Orthop Res 18:713–720PubMedCrossRefGoogle Scholar
  38. 38.
    Boegard T, Rudling O, Petersson IF, Jonsson K (1998) Correlation between radiographically diagnosed osteophytes and magnetic resonance detected cartilage defects in the tibiofemoral joint. Ann Rheum Dis 57:401–407PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Jaanika Kumm
    • 1
    • 2
  • Ann Tamm
    • 3
  • Mare Lintrop
    • 4
  • Agu Tamm
    • 5
  1. 1.Clinic of Internal MedicineUniversity of TartuTartuEstonia
  2. 2.Clinic of RadiologyUniversity of TartuTartuEstonia
  3. 3.Clinic of Sports Medicine and RehabilitationUniversity of TartuTartuEstonia
  4. 4.Clinic of RadiologyUniversity of TartuTartuEstonia
  5. 5.Clinic of Internal MedicineUniversity of TartuTartuEstonia

Personalised recommendations